BMS announces agreement with US Government to improve affordability and access to critical medicines for Americans

BMS

19 December 2025 - Eliquis (apixaban), the nation’s #1 prescribed oral blood thinner, soon available for free to Medicaid program.

BMS today announced an agreement with the US Government to provide Eliquis (apixaban), an oral anticoagulant relied upon by millions of Americans daily, for free to the Medicaid program and to donate more than seven tons of Eliquis active pharmaceutical ingredient to ensure American supply chain resilience. 

The agreement is aligned with BMS’s ongoing commitment to advancing cardiovascular health, improving patient outcomes and collaborating with policymakers on solutions that lower costs for American patients and the healthcare system without jeopardising future innovation.

Read BMS press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing